Osborne Clarke LLP

Osborne Clarke LLP

Region Area

Lawyers

Search rankings
  • search

Matt Lewy

Osborne Clarke LLP

Matt is a partner in the firm's London corporate team with a focus on energy and natural resources. He has wide experience advising on M&A and investment work, and on joint venture and equity arrangements for projects and project financings. This covers renewable energy (including offshore and onshore wind, solar, biomass, energy from waste and electric vehicles), infrastructure, conventional energy and the energy services sector. Matt is co-lead of the firm's carbon capture and hydrogen group. Matt began his career at a London based City firm, working alongside clients and transactions in the wider infrastructure, renewable energy and private equity sectors. He then worked in the London office of an energy focused US firm, focusing on larger international projects and cross border transactions, including with developing markets. Matt has spent time working in both the US and Russia.  Matt also has experience working with mid-market and large cap clients in the TMT sector.

Rhiannon Jones

Rhiannon Jones

Osborne Clarke LLP

Her work involves advising on the design and implementation of employee incentives arrangements for public and private companies, including tax-advantaged and non tax-advantaged share schemes. Rhiannon also advises on the incentives aspects of corporate transactions. Please see full biography at osborneclarke.com/lawyers/rhiannon-jones/

Rob Hayes

Rob Hayes

Osborne Clarke LLP

Rob is a partner in Osborne Clarke's corporate practice and has a particular focus on venture capital work, acting for high growth technology companies and institutional investors on refinancing transactions and company exits. Rob also works with clients in the private equity sector, where he has experience of acting on buyouts, buy-and-build consolidator projects and related exits. Many of Rob's clients operate in the life sciences and tech, media and communications sectors, where the technology has been developed at some of the world's leading research institutions based in the UK. Rob has worked on the legal drafting committee for the BVCA's early stage model documents. He co-leads OC Ventures, the firm's dedicated resource centre for the ventures ecosystem. Rob is head of Osborne Clarke's Thames Valley office.   Please see full biography at osborneclarke.com/lawyers/rob-hayes/

Robert Wood

Robert Wood

Osborne Clarke LLP

Rob is a Partner in Osborne Clarke's corporate practice and advises investors, management teams and companies on all aspects of the private equity market, focusing on venture and growth capital transactions, private equity buyouts, buy-and-build projects and exits. He has particular expertise in advising on complex transactions involving investor syndicates. Much of Rob’s work focuses on the Tech, Media and Comms sector, particularly on high-growth companies trying to bring the latest technology to market. Please see full biography at osborneclarke.com/lawyers/robert-wood/

Robert Guthrie

Robert Guthrie

Osborne Clarke LLP

Rob is a Partner in Osborne Clarke’s Intellectual Property team. He advises clients on all aspects of intellectual property clearance, protection, enforcement and dispute resolution, including trade mark prosecution and the management of global trade mark portfolios. Rob's UK litigation experience ranges from pharmaceutical patent litigation through to high profile trade mark disputes – such as the successful defence of Sky’s Now TV from a passing off claim brought by the operators of a Now TV in Hong Kong; a case which went all the way to the UK’s Supreme Court. Many of Rob's clients operate in fast-moving technology-driven industries – including the interactive entertainment, digital content, fintech and life sciences sectors.

Rupa Lakha

Osborne Clarke LLP

Rupa has extensive experience of both contentious and non-contentious areas of construction law. She has advised on the drafting and negotiation of building contracts and consultants’ appointments and now specialises in dispute resolution, acting regularly for developers, consultants, sub-contractors and consultants in various forms of dispute resolution including mediation, adjudication and litigation.Rupa's recent clients have included RBS, P&O, The Greater London Authority, The Goldsmiths’ Company, Dover Harbour Board, Dorchester Collection, Derwent London Plc, Permasteelisa and Bouygues.Rupa has been ranked in The Legal 500 2017 ‘Next Generation Lawyers’ category for Construction: contentious and non-contentious.

Tom Ellis

Tom Ellis

Osborne Clarke LLP

Tom is a commercial litigation Partner with considerable experience of representing major corporates in high-value and complex commercial disputes, corporate investigations and fraud-related matters. He is regularly retained on matters with an international dimension. He is regularly retained by one of the Big  Four Accountancy firms, certain major American Film and TV corporations, one of the pre-eminent fine art auction houses and various major financial services organisations. Please see full biography at osborneclarke.com/lawyers/tom-ellis/

Trevor Crosse

Osborne Clarke LLP

Trevor is an intellectual property lawyer who advises clients on the commercialisation and enforcement of their IP rights, with a particular focus on patent and licensing disputes in the biotechnology and pharmaceutical sectors. His primary expertise lies in biopharmaceutical patent and SPC litigation, in which he regularly advises clients in relation to complex technical disputes.Trevor has advised clients on actions in the High Court, Court of Appeal and Intellectual Property Enterprise Court, as well as in relation to references to the Court of Justice of the European Union. His work routinely involves multi-jurisdictional disputes and he has significant experience co-ordinating global litigation strategies for his clients.Trevor has been recognised as a rising star by Managing Intellectual Property, IP Stars, 2018. Example CasesEli Lilly v Genentech (Anti-IL17A/F antibodies)Chugai Pharmaceutical Co v UCB Pharma (Antibody humanisation protocols)Fujifilm Kyowa Kirin Biologics v AbbVie (Humira therapy for Crohn’s disease)Fujifilm Kyowa Kirin Biologics v AbbVie (Humira dosing regimen)Hospira UK v Genentech (Herceptin combination therapy)Hospira UK v Genentech (Herceptin formulation)Hospira UK v Genentech (Herceptin dosing regimen)Regeneron Pharmaceuticals v Genentech (VEGF antagonists)MedImmune v Novartis (Phage display)

© 2024 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 2423756 VAT 324572722

Registered address: 188 Fleet Street, London, EC4A 2AG